Advanced

Catching Up In Pharmaceuticals: Government Policies and the Rise of Genomics

Benner, Mats LU (2004) In Australian Health Review 28(2). p.161-170
Abstract
Genomics — the sequencing of the human genome and the identification of the genetic mechanisms of development and disease — is driving a restructuring of the global pharmaceutical industry. Many policy initiatives in biomedicine are based on the assumption that strength in genomics research will be translated into economic success, that is, that investments in genomics will be a way to catch up in the development of the bio-industries. There is therefore intense competition between nations and regions to establish a strong position in genomics, as shown in the growth of public expenditure on biomedical research in the last decade. This article addresses questions regarding the possibility of smaller countries catching up in the bio-based... (More)
Genomics — the sequencing of the human genome and the identification of the genetic mechanisms of development and disease — is driving a restructuring of the global pharmaceutical industry. Many policy initiatives in biomedicine are based on the assumption that strength in genomics research will be translated into economic success, that is, that investments in genomics will be a way to catch up in the development of the bio-industries. There is therefore intense competition between nations and regions to establish a strong position in genomics, as shown in the growth of public expenditure on biomedical research in the last decade. This article addresses questions regarding the possibility of smaller countries catching up in the bio-based economy, given its present concentration within a few research-intensive networks and the historical advantage of established knowledge clusters, which exist primarily in the United States (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
International, Genomics, Studies, Globalization, Competition, R&D, Research & development, Pharmaceutical industry
in
Australian Health Review
volume
28
issue
2
pages
161 - 170
publisher
Australasian Medical Pub. Co. for the Australian Healthcare Association
external identifiers
  • scopus:16544378941
ISSN
1449-8944
language
English
LU publication?
yes
id
9347232a-a3af-4825-b7da-2ee99a55582b (old id 939144)
date added to LUP
2009-06-18 13:01:26
date last changed
2017-01-01 04:54:19
@article{9347232a-a3af-4825-b7da-2ee99a55582b,
  abstract     = {Genomics — the sequencing of the human genome and the identification of the genetic mechanisms of development and disease — is driving a restructuring of the global pharmaceutical industry. Many policy initiatives in biomedicine are based on the assumption that strength in genomics research will be translated into economic success, that is, that investments in genomics will be a way to catch up in the development of the bio-industries. There is therefore intense competition between nations and regions to establish a strong position in genomics, as shown in the growth of public expenditure on biomedical research in the last decade. This article addresses questions regarding the possibility of smaller countries catching up in the bio-based economy, given its present concentration within a few research-intensive networks and the historical advantage of established knowledge clusters, which exist primarily in the United States},
  author       = {Benner, Mats},
  issn         = {1449-8944},
  keyword      = {International,Genomics,Studies,Globalization,Competition,R&D,Research & development,Pharmaceutical industry},
  language     = {eng},
  number       = {2},
  pages        = {161--170},
  publisher    = {Australasian Medical Pub. Co. for the Australian Healthcare Association},
  series       = {Australian Health Review},
  title        = {Catching Up In Pharmaceuticals: Government Policies and the Rise of Genomics},
  volume       = {28},
  year         = {2004},
}